Both Semaglutide GLP-1 and Tirzepatide are very effective in supporting weight loss programs due to the effects that they have on the digestive system to slow down digestion, resulting in the body thinking that it is fuller for longer
This is followed by a compensatory immunosuppressive phase, during which regulatory mechanisms act to restrain inflammation, promote tissue repair, and restore physiological balance 5
We know the drug reduces body weight, but up until now, no one has shown in any group of patients with overweight and obesity that the risk for cardiovascular events could be reduced. Dr
On April 30, 2026, the FDA formally proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list (Federal Register docket 2026-08552), citing no current clinical need for outsourcing facilities to compound these drugs from bulk drug substances